Clinical Trials Browser

Phase 2 × Completed × Klatskin Tumor × Clear all

NCT05024513 2025-12-18

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Phase 2 Completed

Gastrointestinal

Klatskin Tumor

NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT03003065 2023-08-22

PDT

Phase 2 Completed

Gastrointestinal

Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT02042443 2017-09-12

S1310

Phase 2 Completed

53 enrolled 13 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma, Klatskin Tumor

NCT01093222 2015-06-30

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Phase 2 Completed

40 enrolled 16 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Klatskin Tumor